albuterol has been researched along with MS (Multiple Sclerosis) in 5 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response relationship was similar within the non-asthma patients." | 1.40 | Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study. ( Lee, CT; Lin, FC; Tsai, CP, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Almeida, GM | 1 |
| Scola, RH | 1 |
| Ducci, RDP | 1 |
| Cirino, RHD | 1 |
| Cláudia, SKK | 1 |
| Lorenzoni, PJ | 1 |
| Lima, PHS | 1 |
| de Oliveira, LP | 1 |
| Werneck, LC | 1 |
| Tsai, CP | 1 |
| Lin, FC | 1 |
| Lee, CT | 1 |
| Axelrod, S | 1 |
| Bielory, L | 1 |
| Makhlouf, K | 2 |
| Comabella, M | 1 |
| Imitola, J | 1 |
| Weiner, HL | 2 |
| Khoury, SJ | 2 |
1 review available for albuterol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).
Topics: Adjuvants, Immunologic; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; An | 2002 |
1 trial available for albuterol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study.
Topics: Adolescent; Adult; Aged; Albuterol; Brazil; Double-Blind Method; Fatigue; Humans; Middle Aged; Multi | 2020 |
3 other studies available for albuterol and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Case-Control Studies; Child; Chil | 2014 |
Beta2-agonists and paresthesias in multiple sclerosis.
Topics: Adrenergic beta-Agonists; Albuterol; Amantadine; Analgesics, Non-Narcotic; Androstadienes; Aromatase | 2007 |
Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; B7-1 Antigen; Buclades | 2001 |